| The Perfect Fit By Maria, Llc | |
| 22 S Greene Street, #w1l355, Baltimore, Maryland 21201 | |
| (443) 220-0668 |
| Name | The Perfect Fit By Maria, Llc |
|---|---|
| Organization Name | Perfect Fit By Maria, Llc |
| Location | 22 S Greene Street, #w1l355, Baltimore, Maryland 21201 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (443) 220-0668 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Kaiser Health News staff writer Phil Galewitz provides some key details relating to this new way to shop for health insurance coverage (Galewitz, 7/1).
Emergent BioSolutions Inc. today announced that it has been awarded five separate grants under the Qualifying Therapeutic Discovery Project (QTDP) Program to support continued development of its therapeutic programs in oncology and autoimmunity. The grants, with a total value of over $1.2 million, will fund Emergent's TRU-016 Small Modular ImmunoPharmaceutical (SMIP™), DRACO anti-CD3 SMIP, X1 TNF-based SCORPION™, X2 CTLA4-based SCORPION, and T-Scorps-based SCORPION therapeutic programs.
In the search for a cure for Alzheimer's disease, mesenchymal stem cells and their derived extracellular vesicles (MSC-EVs) offer much promise, thanks to their protective and anti-inflammatory properties.
The multi-center study in Sweden and Norway with ChronSeal® is now finalized and the data are being analyzed in Sweden and by Kringle in Japan. ChronTech and Kringle have jointly decided that the results will be publicly available on May 27th. At follow-up of the ChronVac-C® -study where patients now have started treatment according to standard-of-care (interferon and ribavirin) all patients (100%) were virus free at treatment week 12 and 5/6 (83%) had less than 50 copies of virus/mL blood already at treatment week four.
Two new biomarkers for a type of cancer in children called neuroblastoma have been identified in a study published in the journal Cancer Cell. The findings are expected to have immediate significance for disease prognosis, and eventually also for treatment.
› Verified 2 days ago
| NPI Number | 1801206149 |
| Organization Name | PERFECT FIT BY MARIA, LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 22 S Greene St, Wil335, Baltimore, MD 21201 |
| Phone Number | 410-553-0275 |
News Archive
Kaiser Health News staff writer Phil Galewitz provides some key details relating to this new way to shop for health insurance coverage (Galewitz, 7/1).
Emergent BioSolutions Inc. today announced that it has been awarded five separate grants under the Qualifying Therapeutic Discovery Project (QTDP) Program to support continued development of its therapeutic programs in oncology and autoimmunity. The grants, with a total value of over $1.2 million, will fund Emergent's TRU-016 Small Modular ImmunoPharmaceutical (SMIP™), DRACO anti-CD3 SMIP, X1 TNF-based SCORPION™, X2 CTLA4-based SCORPION, and T-Scorps-based SCORPION therapeutic programs.
In the search for a cure for Alzheimer's disease, mesenchymal stem cells and their derived extracellular vesicles (MSC-EVs) offer much promise, thanks to their protective and anti-inflammatory properties.
The multi-center study in Sweden and Norway with ChronSeal® is now finalized and the data are being analyzed in Sweden and by Kringle in Japan. ChronTech and Kringle have jointly decided that the results will be publicly available on May 27th. At follow-up of the ChronVac-C® -study where patients now have started treatment according to standard-of-care (interferon and ribavirin) all patients (100%) were virus free at treatment week 12 and 5/6 (83%) had less than 50 copies of virus/mL blood already at treatment week four.
Two new biomarkers for a type of cancer in children called neuroblastoma have been identified in a study published in the journal Cancer Cell. The findings are expected to have immediate significance for disease prognosis, and eventually also for treatment.
› Verified 2 days ago
News Archive
Kaiser Health News staff writer Phil Galewitz provides some key details relating to this new way to shop for health insurance coverage (Galewitz, 7/1).
Emergent BioSolutions Inc. today announced that it has been awarded five separate grants under the Qualifying Therapeutic Discovery Project (QTDP) Program to support continued development of its therapeutic programs in oncology and autoimmunity. The grants, with a total value of over $1.2 million, will fund Emergent's TRU-016 Small Modular ImmunoPharmaceutical (SMIP™), DRACO anti-CD3 SMIP, X1 TNF-based SCORPION™, X2 CTLA4-based SCORPION, and T-Scorps-based SCORPION therapeutic programs.
In the search for a cure for Alzheimer's disease, mesenchymal stem cells and their derived extracellular vesicles (MSC-EVs) offer much promise, thanks to their protective and anti-inflammatory properties.
The multi-center study in Sweden and Norway with ChronSeal® is now finalized and the data are being analyzed in Sweden and by Kringle in Japan. ChronTech and Kringle have jointly decided that the results will be publicly available on May 27th. At follow-up of the ChronVac-C® -study where patients now have started treatment according to standard-of-care (interferon and ribavirin) all patients (100%) were virus free at treatment week 12 and 5/6 (83%) had less than 50 copies of virus/mL blood already at treatment week four.
Two new biomarkers for a type of cancer in children called neuroblastoma have been identified in a study published in the journal Cancer Cell. The findings are expected to have immediate significance for disease prognosis, and eventually also for treatment.
› Verified 2 days ago
Santa Monica Pharmacy And Medical S Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4300 Belair Rd, Baltimore, Maryland 21206 Phone: (410) 617-0116 | |
Rite Aid Pharmacy 00349 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4380 Park Heights Ave, Baltimore, Maryland 21215 Phone: (410) 664-8644 | |
Rite Aid Pharmacy 02214 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2855 Smith Ave, Baltimore, Maryland 21209 Phone: (410) 484-3200 | |
Rite Aid Pharmacy 00356 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3804 Liberty Heights Ave, Baltimore, Maryland 21215 Phone: (410) 367-5151 | |
Rite Aid Pharmacy 00385 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5804 Ritchie Hwy, Baltimore, Maryland 21225 Phone: (410) 789-3775 |